| scholarly article | Q13442814 |
| P8150 | COVIDWHO ID | covidwho-39610 |
| P6179 | Dimensions Publication ID | 1126111176 |
| P356 | DOI | 10.1016/J.LFS.2020.117627 |
| P932 | PMC publication ID | 7194560 |
| P698 | PubMed publication ID | 32251634 |
| P2093 | author name string | Mohammed Al-Nazawi | |
| Mahmoud Kandeel | |||
| P2860 | cites work | Analysis of preferred codon usage in the coronavirus N genes and their implications for genome evolution and vaccine design | Q84316295 |
| Three Emerging Coronaviruses in Two Decades | Q87461590 | ||
| Recent discovery and development of inhibitors targeting coronaviruses | Q89477874 | ||
| Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission | Q89490397 | ||
| Molecular Characteristics, Functions, and Related Pathogenicity of MERS-CoV Proteins | Q91912232 | ||
| Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus | Q93037598 | ||
| Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein | Q22808780 | ||
| From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design | Q26992345 | ||
| Coronavirus as a possible cause of severe acute respiratory syndrome | Q28200848 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening | Q29617343 | ||
| Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia | Q29618053 | ||
| Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies. | Q30378093 | ||
| SARS-CoV protease inhibitors design using virtual screening method from natural products libraries | Q33211511 | ||
| Coronaviruses - drug discovery and therapeutic options. | Q34513643 | ||
| Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors | Q34530512 | ||
| Ribavirin in the treatment of SARS: A new trick for an old drug? | Q34979709 | ||
| In silico virtual screening approaches for anti-viral drug discovery | Q35200578 | ||
| Introduction of SARS in France, March-April, 2003. | Q35879732 | ||
| Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions | Q36447896 | ||
| Telbivudine: a review of its use in compensated chronic hepatitis B. | Q37788209 | ||
| The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen | Q43545743 | ||
| Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points | Q44904083 | ||
| Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase. Implications for drug discovery | Q46173578 | ||
| Molecular analysis of some camel cytochrome P450 enzymes reveals lower evolution and drug-binding properties. | Q46297814 | ||
| Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus | Q57203441 | ||
| P921 | main subject | virtual screening | Q4112105 |
| COVID-19 | Q84263196 | ||
| SARS-CoV-2 | Q82069695 | ||
| P304 | page(s) | 117627 | |
| P577 | publication date | 2020-04-03 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease | |
| P478 | volume | 251 |
| Q99635028 | Aryl Hydrocarbon Receptor Role in Co-Ordinating SARS-CoV-2 Entry and Symptomatology: Linking Cytotoxicity Changes in COVID-19 and Cancers; Modulation by Racial Discrimination Stress |
| Q96765863 | Coronavirus disease 2019 (COVID-19): challenges and management of aerosol-generating procedures in dentistry |
| Q99547054 | Curcumin, a traditional spice component, can hold the promise against COVID-19? |
| Q98468985 | Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (Mpro) through docking, molecular mechanic & dynamic, and ADMET profiling |
| Q104610691 | SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species |
| Q104439997 | SARS-CoV-2 proteases cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species and the search for reservoir hosts |
| Q94492424 | The Impact of COVID-19 on Vascular Training |
| Q94506619 | Using Integrated Computational Approaches to Identify Safe and Rapid Treatment for SARS -CoV- 2 |
| Q98578804 | Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges |
Search more.